We are a growing international specialist healthcare company. Our mission is to bring to market medical products that meet the needs of specialist healthcare physicians and their patients.
Quote | Btg Plc (OTCMKTS:BTGGF)
Last: | $55.39 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $55.39 |
High: | $0 |
Low: | $0 |
Volume: | 81 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Btg Plc (OTCMKTS:BTGGF)
Boston Scientific (NYSE: BSX ) has completed the acquisition of BTG plc ( OTCPK:BTGGF ). More news on: Boston Scientific Corporation, BTG plc, Healthcare stocks news, Read more ...
Supported by comparative Dosisphere data, a phase II multicentric randomised dosimetry trial LONDON , July 23, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), a global healthcare company, today announced consensus recommendations for personalised treatment for hepatocellular carcinoma (HCC) ...
Message Board Posts | Btg Plc (OTCMKTS:BTGGF)
Subject | By | Source | When |
---|---|---|---|
BTGGF: Acquired. | Renee | investorshub | 08/21/2019 10:29:51 PM |
$BTGGF DD Notes ~ http://www.ddnotesmaker.com/$BTGGF | stocktrademan | investorshub | 11/29/2014 3:48:24 PM |
chartguy89: BTGGF 9.95 Stock Charts $BTGGF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 10:31:31 AM |
chartguy89: BTGGF Stock Charts Monday, February 24, 2014 at 2:34:52 AM $BTGGF Last: -0.0026 | chartguy89 | investorshangout | 02/24/2014 7:35:04 AM |
News, Short Squeeze, Breakout and More Instantly...
Btg Plc Company Name:
BTGGF Stock Symbol:
OTCMKTS Market:
Supported by comparative Dosisphere data, a phase II multicentric randomised dosimetry trial LONDON , July 23, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), a global healthcare company, today announced consensus recommendations for personalised treatment for hepatocellular carcinoma (HCC) ...